The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass

Martin Pellicelli1, Julie A Miller, Alice Arabian

  • 1Research Unit, Shriners Hospitals for Children-Canada, Montreal, Quebec, Canada.

Insights

Parathyroid hormone (PTH) signaling activates protein kinase A (PKA), which phosphorylates the transcriptional coregulator alpha-NAC (αNAC). This phosphorylation drives αNAC nuclear translocation, impacting gene transcription and bone mass regulation.

Area of Science:

  • Bone Biology
  • Molecular Endocrinology
  • Signal Transduction

Background:

  • Parathyroid hormone (PTH) receptor activation initiates cyclic AMP (cAMP) production, activating protein kinase A (PKA).
  • A deficiency in Gα(s) in osteoblasts mirrors a mutation causing cytoplasmic retention of the transcriptional coregulator alpha-NAC (αNAC), suggesting a shared pathway.
  • Understanding the molecular mechanisms linking PTH signaling to transcriptional regulation in bone is crucial for bone mass control.

Purpose of the Study:

  • To investigate the role of the transcriptional coregulator αNAC in PTH-mediated signaling pathways within osteoblasts.
  • To determine if PKA directly phosphorylates αNAC and if this modification affects its cellular localization and function.
  • To elucidate the impact of the Gα(s)-PKA-αNAC axis on bone mass regulation and gene expression.

Main Methods:

  • Treatment of osteoblasts with PTH(1-34) or a PKA-specific activator (6Bnz-cAMP).
  • In vitro kinase assays to assess αNAC phosphorylation by PKA.
  • Analysis of αNAC localization using cell-based assays and mutated variants (S99A, S99D).
  • Chromatin immunoprecipitation (ChIP) to determine αNAC binding to target gene promoters.
  • Assessment of bone mass, osteocyte number, and gene expression (Sost) in compound heterozygous mice.

Main Results:

  • PTH and 6Bnz-cAMP treatment induced nuclear translocation of αNAC in osteoblasts.
  • PKA directly phosphorylated αNAC at serine 99 in vitro.
  • Phosphorylation at S99 was essential for PTH-induced nuclear accumulation of αNAC.
  • αNAC accumulated at the Osteocalcin (Ocn) promoter following PTH or 6Bnz-cAMP stimulation.
  • Compound heterozygous mice for Gα(s) and αNAC exhibited reduced bone mass, increased osteocytes, and elevated Sost expression.

Conclusions:

  • αNAC serves as a direct substrate for PKA downstream of PTH receptor signaling.
  • PKA-mediated phosphorylation of αNAC at S99 promotes its nuclear translocation.
  • Nuclear accumulation of αNAC at target promoters regulates gene transcription involved in bone mass.
  • The Gα(s)-PKA-αNAC pathway is a critical regulator of bone homeostasis.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K